Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease

Overview of attention for article published in Frontiers in immunology, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 55,527 followers.

Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease: Chronic graft-versus-host disease (cGVHD) remains a frequent cause of… #immunology https://t.co/2B9PU

20 Sep 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients wit…

15 Sep 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients wit…

14 Sep 2022

Reply Repost Favourite

New Research: Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease: Chronic graft-versus-host disease (cGVHD) remains a frequent cause of… https://t.co/luv

14 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.